rs750495319
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP3BS2
The NM_001754.5(RUNX1):c.1098_1103delCGGCAT(p.Ile366_Gly367del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000836 in 1,435,436 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★★). Synonymous variant affecting the same amino acid position (i.e. I366I) has been classified as Likely benign.
Frequency
Consequence
NM_001754.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000499 AC: 1AN: 200284 AF XY: 0.00000924 show subpopulations
GnomAD4 exome AF: 0.00000836 AC: 12AN: 1435436Hom.: 0 AF XY: 0.00000843 AC XY: 6AN XY: 711532 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1098_1103delCGGCAT variant (also known as p.I366_G367del) is located in coding exon 8 of the RUNX1 gene. This variant results from an in-frame CGGCAT deletion at nucleotide positions 1098 to 1103. This results in the in-frame deletion of two amino acids (IG) at codons 366 and 367. This variant was reported as germline in an individual with acute myeloid leukemia (AML) diagnosed at age 52 (Mendler JH et al. Haematologica, 2013 Aug;98:e92-4). These amino acid positions are well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Uncertain:1
NM_001754.5(RUNX1):c.1098_1103del p.(Ile366_Gly367del) is an inframe deletion which does not meet any ACMG/AMP criteria. In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: None. -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
This variant, c.1098_1103del, results in the deletion of 2 amino acid(s) of the RUNX1 protein (p.Ile366_Gly367del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs756287155, gnomAD 0.001%). This variant has been observed in individual(s) with acute myeloid leukemia (PMID: 23753029). ClinVar contains an entry for this variant (Variation ID: 971769). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at